关联非因果:无法从观察性数据估计心力衰竭的治疗效应
该研究系统检索截至2017年12月31日的文献,比较非随机观察性研究与随机对照试验(RCT)关于心力衰竭药物治疗对全因死亡率效应的结论。共纳入92篇出版物、94项非随机研究、158个效应估计,涉及六类药物与25项RCT;以盐皮质激素受体拮抗剂(MRA)为例,12项非随机研究中仅1项显示获益,而关键RCT显示MRA降低射血分数降低心衰患者死亡率。结论认为不能从观察性关联做出可靠的治疗推断,RCT仍是治疗患者的最佳指南。
要点
- 观察性研究推断心衰药物疗效不可靠,可能与RCT结论冲突。
- MRA的12项非随机研究中仅1项显示获益,而关键RCT显示降低死亡率。
- RCT虽存在证据缺口和选择人群,仍是心衰治疗决策的最佳依据。
核心结论
- 不能从观察性关联中做出可靠的心衰治疗推断。
- RCT仍是指导心衰患者治疗的最佳依据。
研究设计与样本
- 检索Medline和Embase至2017年12月31日,纳入非随机药物治疗与心衰患者全因死亡率关联的研究。
- 共纳入92篇出版物、94项非随机研究,报告158个效应估计,涉及六类药物。
- 六类药物已在25项RCT中测试,研究将观察性研究结果与相关RCT比较。
主要发现
- 以MRA为例,两项关键RCT显示其降低射血分数降低心衰患者死亡率。
- 12项非随机研究中仅1项发现MRA获益,10项为中性效应,1项为有害效应。
临床怎么用
- 心衰治疗决策应以RCT证据为主要依据,不宜依据非随机观察性关联推断疗效。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: Treatment 'effects' are often inferred from non-randomized and observational studies. These studies have inherent biases and limitations, which may make therapeutic inferences based on their results unreliable. We compared the conflicting findings of these studies to those of prospective randomized controlled trials (RCTs) in relation to pharmacological treatments for heart failure (HF). METHODS AND RESULTS: We searched Medline and Embase to identify studies of the association between non-randomized drug therapy and all-cause mortality in patients with HF until 31 December 2017. The treatments of interest were: angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, beta-blockers, mineralocorticoid receptor antagonists (MRAs), statins, and digoxin. We compared the findings of these observational studies with those of relevant RCTs. We identified 92 publications, reporting 94 non-randomized studies, describing 158 estimates of the 'effect' of the six treatments of interest on all-cause mortality, i.e. some studies examined more than one treatment and/or HF phenotype. These six treatments had been tested in 25 RCTs. For example, two pivotal RCTs showed that MRAs reduced mortality in patients with HF with reduced ejection fraction. However, only one of 12 non-randomized studies found that MRAs were of benefit, with 10 finding a neutral effect, and one a harmful effect. CONCLUSION: This comprehensive comparison of studies of non-randomized data with the findings of RCTs in HF shows that it is not possible to make reliable therapeutic inferences from observational associations. While trials undoubtedly leave gaps in evidence and enrol selected participants, they clearly remain the best guide to the treatment of patients.
引用
- Rush CJ, Campbell RT, Jhund PS, et al. Association is not causation: treatment effects cannot be estimated from observational data in heart failure. Eur Heart J. 2018. PMID: 30085087. doi:10.1093/eurheartj/ehy407
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。